35 research outputs found

    Correction:How the COVID-19 pandemic highlights the necessity of animal research (vol 30, pg R1014, 2020)

    Get PDF
    (Current Biology 30, R1014–R1018; September 21, 2020) As a result of an author oversight in the originally published version of this article, a number of errors were introduced in the author list and affiliations. First, the middle initials were omitted from the names of several authors. Second, the surname of Dr. van Dam was mistakenly written as “Dam.” Third, the first name of author Bernhard Englitz was misspelled as “Bernard” and the surname of author B.J.A. Pollux was misspelled as “Pullox.” Finally, Dr. Keijer's first name was abbreviated rather than written in full. These errors, as well as various errors in the author affiliations, have now been corrected online

    Abstinence-dependent dissociable central amygdala microcircuits control drug craving

    No full text
    We recently reported that social choice-induced voluntary abstinence prevents incubation of methamphetamine craving in rats. This inhibitory effect was associated with activation of protein kinase-Cδ (PKCδ)-expressing neurons in central amygdala lateral division (CeL). In contrast, incubation of craving after forced abstinence was associated with activation of CeL-expressing somatostatin (SOM) neurons. Here we determined the causal role of CeL PKCδ and SOM in incubation using short-hairpin RNAs against PKCδ or SOM that we developed and validated. We injected two groups with shPKCδ or shCtrlPKCδ into CeL and trained them to lever press for social interaction (6 d) and then for methamphetamine infusions (12 d). We injected two other groups with shSOM or shCtrlSOM into CeL and trained them to lever press for methamphetamine infusions (12 d). We then assessed relapse to methamphetamine seeking after 1 and 15 abstinence days. Between tests, the rats underwent either social choice-induced abstinence (shPKCδ groups) or homecage forced abstinence (shSOM groups). After test day 15, we assessed PKCδ and SOM, Fos, and double-labeled expression in CeL and central amygdala medial division (CeM). shPKCδ CeL injections decreased Fos in CeL PKCδ-expressing neurons, increased Fos in CeM output neurons, and reversed the inhibitory effect of social choice-induced abstinence on incubated drug seeking on day 15. In contrast, shSOM CeL injections decreased Fos in CeL SOM-expressing neurons, decreased Fos in CeM output neurons, and decreased incubated drug seeking after 15 forced abstinence days. Our results identify dissociable central amygdala mechanisms of abstinence-dependent expression or inhibition of incubation of craving

    Treatment with low doses of nicotine but not alcohol affects social play reward in rats

    No full text
    Social play behaviour is a vigorous, highly rewarding activity inyoung animals. It is thought to facilitate social, cognitive andemotional development, but its underlying neural mechanisms areincompletely understood. Previously, we found that low doses ofalcohol and nicotine enhanced social play behaviour in youngrats. Using place and operant conditioning setups to assess thepleasurable and motivational aspects of social play, weinvestigated how treatment with nicotine and alcohol affectssocial play reward. Nicotine-treatment increased the incentivemotivational properties of social play as well as the expression ofsocial play itself. Moreover, while nicotine by itself evokedconditioned place preference (CPP), it reduced social play-inducedCPP. Alcohol-treatment did not affect the motivation for andexpression of social play, nor did it affect social play-induced CPP.Thefinding that nicotine but not alcohol modulates social playreward increases our understanding of the neural underpinningsof this developmentally important behaviour

    Special Issue on the Behavioural Pharmacology of Cannabinoids

    No full text

    The behavioural pharmacology of opioids

    No full text

    Translational Research in Behavioural Pharmacology

    No full text

    Editorial: The Behavioural Pharmacology of Cannabinoids

    No full text
    corecore